We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Altea Therapeutics Begins Clinical Trials for Chronic Pain Patch
Altea Therapeutics Begins Clinical Trials for Chronic Pain Patch
June 2, 2006
Altea Therapeutics announced May 25 it has begun Phase I clinical trials in the U.S. for AT3022, a fentanyl citrate transdermal patch to treat severe chronic pain.